Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study

Clinical trial NCT03260101 · UNKNOWN

Trial details

NCT number: NCT03260101
Sponsor: Cellect Biotechnology
Status: UNKNOWN
Study type: OBSERVATIONAL

Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)Hodgkin Lymphoma, Adult

Start date: 2018-06-10
Primary completion: 2021-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.